Entest Biomedical Inc (ENTB.PK)

ENTB.PK on OTC Markets Group

0.00USD
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,664,192
52-wk High
$0.00
52-wk Low
$0.00

ENTB.PK

Chart for ENTB.PK

About

Entest BioMedical, Inc. (Entest) is a development-stage company. During the fiscal year ended August 31, 2012, the Company’s business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is... (more)
No analyst recommendations are available for ENTB.PK.

Overall

Beta: 3.42
Market Cap (Mil.): $0.24
Shares Outstanding (Mil.): 2,405.57
Dividend: --
Yield (%): --

Financials

  ENTB.PK Industry Sector
P/E (TTM): -- 26.33 38.03
EPS (TTM): -0.00 -- --
ROI: -- 7.72 18.26
ROE: -- 11.98 19.16
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks